A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy
Dulguun Amgalan, Thomas P. Garner, Ryan Pekson, Xiaotong F. Jia, Mounica Yanamandala, Victor M. Paulino, Felix G. Liang, J. Jose Corbalan, Jaehoon Lee, Yun Chen, George S. Karagiannis, Luis Rivera Sanchez, Huizhi Liang, Swathi-Rao Narayanagari, Kelly Mitchell, Andrea López, Victoria Margulets, Marco Scarlata, Gaetano Santulli, Aarti Asnani, Randall T. Peterson, Rachel B. Hazan, John S. Condeelis, Maja H. Oktay, Ulrich Steidl, Lorrie A. Kirshenbaum, Evripidis Gavathiotis, Richard N. Kitsis
Topics & Concepts
DoxorubicinAllosteric regulationSmall moleculeChemistryCardiomyopathyPharmacologyCancer researchMedicineBiochemistryInternal medicineHeart failureEnzymeChemotherapyChemotherapy-induced cardiotoxicity and mitigationElectron Spin Resonance StudiesCoenzyme Q10 studies and effects